Comparison

Phenylephrine European Partner

Item no. HY-B0769-500mg
Manufacturer MedChem Express
CASRN 59-42-7
Amount 500 mg
Quantity options 10 mM/1 mL 200 mg 500 mg
Category
Type Inhibitors
Specific against other
Purity 99.98
Citations [1]Ford AP, et al. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications foralpha1-adrenoceptor classification. Br J Pharmacol. 1997 Jul;121(6):1127-35.|[2]Minneman KP, et al. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol. 1994 Nov;46(5):929-36.|[3]Wang J, et al. Phenylephrine promotes cardiac fibroblast proliferation through calcineurin-NFAT pathway. Front Biosci (Landmark Ed). 2016 Jan 1;21:502-13.|[4]Lazou A, et al. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart. Biochem J. 1998 Jun 1;332 ( Pt 2):459-65.|[5]Li NJ, et al. Effect of phenylephrine on alveolar fluid clearance in ventilator-induced lung injury. Chin Med Sci J. 2013 Mar;28(1):1-6.
Biochem Biophys Res Commun. 2024 Oct 17:735:150844.|Biochim Biophys Acta Mol Basis Dis. 2023 Aug 27;166859.|Biochim Biophys Acta Mol Basis Dis. 2024 Aug 30:167488.|BMC Cardiovasc Disord. 2025 Jan 6;25(1):7.|BMC Pulm Med. 2021 Jun 5;21(1):189.|Eur J Pharmacol. 2025 Feb 1:177346.|Front Med. 2024 May 14.|J Cardiovasc Pharmacol. 2022 Sep 1;80(3):430-441.|J Endod. 2023 Sep 26:S0099-2399(23)00608-8.|J Ethnopharmacol. 2024 Aug 22:118707.|Mol Med Rep. July 6, 2021.|Nat Commun. 2024 Jul 16;15(1):5985.|Sci Rep. 2023 Oct 2;13(1):16550.|Trends Biotechnol. 2025 Jan 7:S0167-7799(24)00355-X.|Elife. 2024 May 29.|Free Radic Biol Med. 2024 Jan 6:S0891-5849(24)00007-8.|Front Cardiovasc Med. 2021 Jun 16;8:679240.|J Cell Mol Med. 2025 Mar;29(5):e70488.|J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:220-227.
Smiles O[C@H](C1=CC(O)=CC=C1)CNC
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias (R)-(-)-Phenylephrine,L-Phenylephrine
Similar products 59-42-7
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Metabolism-protein/nucleotide metabolism
Manufacturer - Targets
Adrenergic Receptor
Shipping Temperature
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight
167.208
Product Description
(R)-(-)-Phenylephrine is a selective α1-adrenoceptor agonist primarily used as a decongestant.
Manufacturer - Research Area
Cardiovascular Disease; Endocrinology; Cancer
Solubility
DMSO: 50 mg/mL (ultrasonic)|H2O: 5 mg/mL (ultrasonic)
Manufacturer - Pathway
GPCR/G Protein; Neuronal Signaling
Isoform
α adrenergic receptor
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close